Denosumab linked to lower fracture risk

24 August 2009 | by Amy Corderoy Print this article Comments Share this article
 Denosumab given subcutaneously twice yearly for 36 months is associated with a reduction in the risk of vertebral, nonvertebral, and hip fractures in women with osteoporosis, a study finds....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites